Help Patients Get to Goal With Heart Failure Meds

January 2023

Questions will come up about the best way to titrate meds for heart failure with reduced ejection fraction (HFrEF).

Less than 1% of patients are on target-dose “triple therapy” with an ACEI, ARB, or Entresto (sacubitril/valsartan)...an evidence-based beta-blocker (carvedilol, etc)...and an aldosterone antagonist.

Even fewer get the latest guideline-recommended “quad therapy” for HFrEF...by adding an SGLT2 inhibitor (Farxiga, etc).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Opioids Use New Guidelines to Reinforce Safe Opioid Use
Biologics Know Key Points About Immunosuppressive Biologics
Heart Failure Help Patients Get to Goal With Heart Failure Meds
Gastroenterology Reevaluate Management of Acute Pancreatitis
Oral Health Limit Med Changes Before Dental Procedures
Med Safety Ensure Safety With Antiseizure Meds
Constipation Sort Out OTC and Rx Options for Constipation
Pediatrics Stay Alert for Anxiety and Depression in Kids
Practice Be Aware of Tools to Support Shared Decision-Making
Endocarditis Guide Treatment for Endocarditis Due to Injection Drug Use
Liver Disease Assess Terlipressin for Hepatorenal Syndrome

Help Patients Get to Goal With Heart Failure Meds

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents